Bio-Thera
Solutions, Ltd., a leading innovative, global biopharmaceutical company in
Guangzhou, China, is dedicated to researching and developing novel therapeutics
for the treatment of cancer, autoimmune, cardiovascular, eye diseases, and
other severe unmet medical needs, as well as biosimilars for existing, branded
biologics to treat a range of cancer and autoimmune diseases. As a leader in
global antibody discovery and engineering, the company has advanced
multiple drugs into market, including four approved
products: QLETLI? and BETAGRIN?(Bevifibatide Citrate Injection) in China, and
TOFIDENCE/ BAT1806 and Avzivi? / Pobevcy? in the US, EU and China. TOFIDENCE is the first monoclonal antibody drug researched, developed, manufactured by a Chinese pharmaceutical company to receive FDA approval in the United States.
